Acting Head Named For Office Of Women's Health
This article was originally published in The Pink Sheet Daily
Theresa Toigo will serve as the acting director of FDA's Office of Women's Health, the agency announced Sept. 16
You may also be interested in...
Susan Wood says she can “no longer serve as staff when scientific and clinical evidence...has been overruled.”
The forthcoming report also will show increased disclosure of company sponsors and drug names in trial descriptions. FDA has added language to IND acknowledgement letters to promote compliance with listing requirements.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.